Make your money go further for just 25p per day

Whopping contract | FDA approval | Another offer

02/11/2023 · Cerillion (CER) · Creo Medical (CREO) · Equals Group PLC (EQLS) · Oxford Metrics (OMG) · Premier Miton Group (PMI) · Sopheon

AIM AIM Inheritance Tax potential UK

Our free update here includes news of yet another significant contract win for a high-performing AIM software company. Elsewhere, two companies are starting to put their significant cash piles to hopefully better use with acquisitions, while yet another AIM company is under offer, this time for a big premium. Read on here for this and other news.

Cerillion secures another whopper

Cerillion (AIM:CER), the creator of software for billing, charging and customer relationship management, has announced another significant contract win to add further support to its lofty valuation.

Cerillion has signed a major new contract, worth an initial €12.4m, with a Tier-1 telecommunications provider, based in Europe.

Cerillion will be supplying and implementing the core elements of its flagship solution, including billing, charging, fulfilment and product catalogue, on…

Sign up and read the full article

Register to continue reading our content.

Get FREE access now

Already a member? Login

Previous article Next article

More on Cerillion

Cracking results | Tough in ad world | Big contract woes

25/11/2025 · Company Insights

News covered here includes our assessment of excellent full year results from a provider of software…

AIM investors stitched-up | Another takeover offer

24/10/2025 · Company Insights

The latest company to announce a move to the Main Market from AIM, hasn’t given much…

More on Creo Medical

Episode 18 of the Investor’s Champion Podcast

18/05/2024 · Podcasts

In this episode of the Investor’s Champion Podcast Chris and Lee consider the recent highs of…

Innovators think big

15/05/2024 · Company Insights

It’s tough being an innovator, but should things develop as intended, the potential rewards can be huge.…

More on Equals Group PLC

Compelling value | Debt worries

16/01/2024 · Company Insights

News covered here include trading updates from two main market small caps, with one looking considerably more…

Whopping contract | FDA approval | Another offer

02/11/2023 · Company Insights

Our free update here includes news of yet another significant contract win for a high-performing AIM…

More on Oxford Metrics

Angel delight | Cash flow drag | Restoring confidence

09/12/2025 · Company Insights

News covered here includes our assessment of results from two professional services groups, both of whom…

Great results | Whopping contracts | Capital efficiency

06/12/2023 · Company Insights

A small company covered here has issued excellent results and sits on a very large cash…

More on Premier Miton Group

Trustpilot tanks | Nuclear returns | Dividend delights

04/12/2025 · Company Insights

Shares in highly-rated Trustpilot tumble as a short seller attacks the integrity of its reviews and…

American growth | Appealing dividends | Musical chairs

14/10/2025 · Company Insights

A manufacturer of infection prevention products looks well-placed to grow in North America, but it might…

More on Sopheon

Whopping contract | FDA approval | Another offer

02/11/2023 · Company Insights

Our free update here includes news of yet another significant contract win for a high-performing AIM…

Hidden value | Questionable cash flow

30/01/2023 · Company Insights

Updates from AIM covered here include the realisation of some hidden value in an engineering group, where…

More on Cerillion

Cracking results | Tough in ad world | Big contract woes

AIM investors stitched-up | Another takeover offer

Quality companies | Bonkers Bargain update | Another offer

Stonking Small Cap strength | Big dividend payer | Energy growth

More on Creo Medical

Episode 18 of the Investor’s Champion Podcast

Innovators think big

Whopping contract | FDA approval | Another offer

Impairments | Dividend reinstatement | Bonkers Bargain

More on Equals Group PLC

Compelling value | Debt worries

Whopping contract | FDA approval | Another offer

Fintech finesse | Dividend hikes | Cash flow conundrums

Looking good | Puzzling valuations | Stonking Small Cap update

More on Oxford Metrics

Angel delight | Cash flow drag | Restoring confidence

Great results | Whopping contracts | Capital efficiency

Whopping contract | FDA approval | Another offer

Cash support | Strange departures | Bonkers Bargains

More on Premier Miton Group

Trustpilot tanks | Nuclear returns | Dividend delights

American growth | Appealing dividends | Musical chairs

Appealing dividends | Excellent results | Trading ahead

Stunning results | Big dividend payers | Derisory margins

More on Sopheon

Whopping contract | FDA approval | Another offer

Hidden value | Questionable cash flow

The good and the puzzling!

Highly rated: can they deliver?

Intoxicating development | Anything left for shareholders? | Selling the silver

Bonkers Bargains: record revenues and profits

Kitchen sinking it | US growth | Big second half

ABOUT INVESTORS CHAMPION

Investor's Champion offers objective, incisive and forthright comment on quoted companies and personal finance. Our content addresses what we believe are the key issues in helping make your money go further.

Investor's Champion is a registered trade mark of Microfact Limited. Microfact Limited is a company registered in England and Wales under number 03577867 whose registered office is at c/o Cox Costello & Horne, Batchworth Lock House, 99 Church Street, Rickmansworth, WD3 1JJ.

All rights reserved. © 2007 - 2025